BioSpace News Archive

The increasing prevalence of cancer cases and the advent of the latest technology to combat various cancer types emerge as a prime factor augmenting the growth of the global radiotherapy market.

More than 7000 types of rare diseases affect more than 30 million people in the U.S. alone. Approximately 80% of the rare diseases are found to be genetic.

The occurrence of psoriatic arthritis can place an extremely negative toll on the overall health of individuals.

The two main types of materials of contact lenses are soft and hard or rigid. Scleral lens is a type of hard or rigid material contact lens, and it’s generally larger in diameter than other contact lenses.

Preeclampsia is a hypertensive disorder of pregnancy and affects about 5% of pregnant women globally, out of whom 0.5% to 1% develop it in the severe form.

The over-the-counter pain medication market is predicted to display notable growth over the forecast period from 2020 to 2030.

Fact.MR – A Market Research and Competitive Intelligence Provider: As per insights by Fact.MR, the global market for multiphoton microscopy is expected grow at a CAGR of nearly 5% over the forecast period 2021-2031, owing to the increasing adoption of multiphoton microscopy in the cancer research centres.

Targovax ASA, announces that members of its executive management team is invited to present and participate at upcoming conferences.

Oxurion NV, a biopharmaceutical company developing next generation standard of care therapies for retinal vascular disorders, announces the publication of two related papers in the Journal of Pharmacokinetics and Pharmacodynamics entitled “Systemic exposure following intravitreal administration of therapeutic agents: an integrated pharmacokinetic approach.”

Occlutech Holding AG announces the conditional U.S. Food and Drug Administration approval of its Investigational Device Exemption application to conduct a pivotal study, OCCLUFLEX, comparing Patent Foramen Ovale closure by Occlutech’s Flex II PFO Occluder to the standard of care for PFO occlusion in patients with cryptogenic stroke.